Clinical trials
MG clinical trials
Below are recruiting mg clinical trials, each written for real people, not researchers. We’re tracking 936 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07242131Recruiting
Birth control, progesterone, or inositol for regulating periods in PCOS
This trial tests three treatments—birth control pills, progesterone, and inositol—to see which best helps regulate menstrual cycles in women with PCOS. It aims to find an effective option that is safe and easy to use.
Izmir, MenemenAges 18–40 - NCT07247734RecruitingPhase 2
Colchicine for insulin sensitivity in type 1 diabetes
This trial tests whether a daily oral medication called colchicine can improve how your body responds to insulin. It is for people with type 1 diabetes who have ongoing low-level inflammation and are already using a continuous glucose monitor.
Gentofte MunicipalityAges 18–80 - NCT07242456RecruitingPhase 2/Phase 3
Comparing two treatments for H. pylori infection
This study tests two different combinations of medications to treat H. pylori, a stomach bacteria that can cause ulcers. You would take one of the two combinations for a short time to see which works better at getting rid of the infection.
Hangzhou, ZhejiangAges 18–70 - NCT07236372Recruiting
Comparing two doses of cetirizine for sudden hives
This trial tests whether a higher dose of cetirizine (an allergy medicine) works better than the standard dose for treating sudden hives in adults. It may help people who have had new hives in the last day and are not taking certain other medicines.
Phayao, MueangAges 18–60 - NCT07238400RecruitingPhase 2
Heart medication study for women after preeclampsia
This study tests if a medication called a mineralocorticoid receptor antagonist (MRA) can help improve heart function in women who had preeclampsia and now have high blood pressure and signs of heart thickening.
Boston, MassachusettsAges 18–65 - NCT07232069RecruitingPhase 3
Early heart disease trial for women and men with mild plaque buildup
This trial tests whether two medicines, a statin and colchicine, can slow or stop early heart artery plaque from growing in people who have mild plaque but no heart disease symptoms yet. It uses special CT scans to measure plaque over 2 years.
Birmingham, AlabamaAges 30–60 - NCT07228195RecruitingPhase 4
Study on SGLT2i therapy after islet transplantation
This trial tests whether a diabetes medication called empagliflozin (an SGLT2 inhibitor) can help people who have had an islet transplant (TPIAT) better manage their blood sugar. It aims to see if it improves how well the transplanted islets work.
Minneapolis, MinnesotaAges 18–70 - NCT07223541RecruitingPhase 2
Immunotherapy and targeted radiation for advanced kidney cancer
This study tests a new immunotherapy drug (cemiplimab), either alone or combined with another drug (fianlimab), after targeted radiation (SBRT) to kill cancer cells. It is for people with advanced clear cell kidney cancer who have few spots of spread and have not had many prior treatments.
Oklahoma City, OklahomaAges 18 years+ - NCT07220538RecruitingPhase 4
Ginkgo biloba for memory problems after a mild stroke
This trial tests whether adding ginkgo biloba extract tablets to standard stroke care helps improve memory and thinking in people who had a mild stroke. You may join if you are 55 or older, had a mild stroke in the last 1 to 2 weeks, and now have some cognitive difficulties.
AnyangAges 55 years+ - NCT07216690RecruitingPhase 2
Pregnenolone for cannabis intoxication
This study tests whether a natural hormone called pregnenolone can reduce the effects of cannabis intoxication. You'll receive either the study drug or a placebo, then eat a cannabis-containing brownie to see how your body reacts.
Baltimore, MarylandAges 18–65 - NCT06555575RecruitingPhase 2
CoQ10 supplement for women starting IVF
This trial tests two forms of coenzyme Q10 (ubiquinone vs. ubiquinol) to see if either improves egg quality or IVF success. It may be a good fit if you are between 37 and 43, doing your first IVF cycle, and have certain hormone levels within a normal range.
Toronto, OntarioAges 37–43 - NCT05564936Recruiting
Digital tests for generalized myasthenia gravis using a smartphone
This study tests a smartphone-based digital tool that helps check symptoms in people with generalized myasthenia gravis (MG). It may help patients and clinicians track how the disease is doing over time using simpler, repeated assessments.
Aurora, ColoradoAges 18 years+ - NCT07210684Recruiting
Dihydroberberine for blood sugar, appetite, and mood in prediabetes
This study tests a supplement called dihydroberberine (DHB) to see if it helps improve blood sugar control, appetite, and mood in adults with prediabetes. You will wear a small sensor to track your blood sugar and use a phone app to record what you eat.
Addison, IllinoisAges 35–65 - NCT07203339Recruiting
Home brain stimulation vs. duloxetine for fibromyalgia pain
This trial compares a non-invasive, at-home brain stimulation technique (tDCS) to the medication duloxetine for treating fibromyalgia pain. It aims to see if the brain stimulation works as well as the drug.
Porto Alegre, Rio Grande do SulAges 18–75 - NCT07210112RecruitingPhase 2
Psilocybin and Trazodone for tough-to-treat depression
This trial tests if taking psilocybin (a psychedelic drug) with trazodone (an antidepressant) can help people whose depression hasn't improved with at least two standard antidepressants. If you have treatment-resistant depression, this study might be an option.
ParisAges 18 years+ - NCT06837922RecruitingPhase 3
Study of MG-K10 for moderate to severe asthma
This trial tests a new drug called MG-K10 for people with moderate to severe asthma that is not well controlled with current treatments. It aims to see if the drug can reduce asthma attacks and improve breathing. You may be able to join if you have had asthma for at least a year, use high-dose inhalers plus another controller medicine, and have had a recent flare-up.
Guangzhou, GuangdongAges 12–75 - NCT06846385RecruitingPhase 2/Phase 3
Testing a new shot for severe seasonal hay fever
This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.
Beijing, Beijing MunicipalityAges 18–75 - NCT07193459RecruitingPhase 3
Study of an oral tablet for type 2 diabetes
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
Beijing, Beijing MunicipalityAges 18–75 - NCT07195331RecruitingPhase 4
Comparing dye doses for clearer bile duct images during gallbladder surgery
This trial tests two different doses of a special dye (indocyanine green) to see which one gives surgeons a clearer view of the bile ducts during gallbladder removal. The goal is to help make the surgery safer and reduce the risk of injury.
Salamanca, SalamancaAges 18 years+ - NCT07200544RecruitingPhase 4
Meloxicam for skin cancer surgery pain
This study tests if meloxicam, an anti-inflammatory painkiller, helps control pain after Mohs surgery for skin cancer. It aims to reduce the need for stronger opioid pain medicines.
Oklahoma City, OklahomaAges 18–110 - NCT07182526RecruitingPhase 2
Quercetin or alpha lipoic acid for PCOS symptoms
This trial tests adding quercetin or alpha lipoic acid to standard PCOS care to see if they improve symptoms and blood markers. It may help women who have irregular periods or signs of excess androgens like acne.
Baghdad, KarkhAges 18 years+ - NCT07168434RecruitingPhase 3
Yeast supplement for irritable bowel syndrome (IBS)
This trial tests if a yeast supplement called Saccharomyces boulardii can help people with irritable bowel syndrome (IBS), except for those with constipation as their main symptom. Participants take the supplement and see if their symptoms improve.
BragaAges 18–65 - NCT05570149Recruiting
Study of eptinezumab in people with frequent migraine
This real-world study looks at how well eptinezumab (an antibody medicine for migraine prevention) works for people with frequent episodic or chronic migraine as they get usual care. You may be asked to share health information and treatment details to see what helps most in everyday life.
Roma, RMAges 18–75 - NCT07164183RecruitingPhase 3
Comparing two drugs for endometriosis pain relief
This study tests if a new drug called Indinol Forto works as well as the standard drug Visanne for reducing endometriosis-related pelvic pain. It is for women with surgically confirmed endometriosis who have regular cycles and moderate to severe pain.
Kazan'Ages 18–45
Hear when a new MG trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for mg?
- Yes. Clin2 currently lists 936 recruiting mg studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a mg trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a mg trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.